Home › Ovarian Cancer › Colorado › Fort Collins
Ovarian Cancer clinical trials in Fort Collins, CO
5 studies for Ovarian Cancer are looking for participants at sites in and around Fort Collins (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Vanguard Study: Testing a New Way to Screen for Cancer
RecruitingHealthy volunteers welcome
- Poudre Valley Hospital, Fort Collins
- Cancer Care and Hematology-Fort Collins, Fort Collins
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Poudre Valley Hospital, Fort Collins
- Cancer Care and Hematology-Fort Collins, Fort Collins
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Recruiting
- Poudre Valley Hospital, Fort Collins
- Cancer Care and Hematology-Fort Collins, Fort Collins
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Poudre Valley Hospital, Fort Collins
- Cancer Care and Hematology-Fort Collins, Fort Collins
Survivors Uniting for Remote Guided Exercise
Recruiting
- Human Performance Clinical Research Lab, Fort Collins
About Ovarian Cancer
Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.
More about Ovarian Cancer on MedlinePlus
Ovarian Cancer trials in other cities
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
Other studies in Fort Collins
- Lung Cancer8 studies
- Breast Cancer6 studies
- Non-Small Cell Lung Cancer6 studies
- Prostate Cancer6 studies
- Cancer (all types)4 studies
- Bladder Cancer4 studies
- Colon Cancer4 studies
- Metastatic Cancer3 studies
- Metabolic Disorders3 studies
- Insulin Resistance3 studies
- Multiple Myeloma3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.